Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on July 14, 2026

6 hours ago

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire

6 hours ago

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire

6 hours ago

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Indeterminate GlobeNewswire

6 hours ago

Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry

Indeterminate GlobeNewswire

7 hours ago

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Indeterminate GlobeNewswire

7 hours ago

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Indeterminate GlobeNewswire

7 hours ago

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire

8 hours ago

Texas Hemp Business Council Releases New Public Health Analysis on THC Regulation and Public Health Priorities

Indeterminate GlobeNewswire

8 hours ago

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Indeterminate GlobeNewswire

9 hours ago

Nucleome Therapeutics strengthens global IP portfolio with US patent for core MCC Technology

Indeterminate GlobeNewswire

9 hours ago

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

Indeterminate GlobeNewswire

10 hours ago

ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026

Indeterminate GlobeNewswire

14 hours ago

Erasca Announces Pricing of Upsized Public Offering of Common Stock

Indeterminate GlobeNewswire

15 hours ago

Tevogen Bio Announces 2026 Annual Meeting of Stockholders

Indeterminate GlobeNewswire

15 hours ago

Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

16 hours ago

Capilea México Releases Overview of Hair Transplant Success Rates and FUE Technology in Mexico

Indeterminate GlobeNewswire

16 hours ago

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

Indeterminate GlobeNewswire